Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White Paper.

West MA, Hwang S, Maier RV, Ahuja N, Angelos P, Bass BL, Brasel KJ, Chen H, Davis KA, Eberlein TJ, Fong Y, Greenberg CC, Lillemoe KD, McCarthy MC, Michelassi F, Numann PJ, Parangi S, Reyes JD, Sanfey HA, Stain SC, Weigel RJ, Wren SM.

Ann Surg. 2018 Sep;268(3):403-407. doi: 10.1097/SLA.0000000000002937.

PMID:
30004923
2.

Interim Analysis of a Prospective Multi-Institutional Study of Surgery Resident Experience with Flexibility in Surgical Training.

Cullinan DR, Wise PE, Delman KA, Potts JR, Awad MM, Eberlein TJ, Klingensmith ME.

J Am Coll Surg. 2018 Apr;226(4):425-431. doi: 10.1016/j.jamcollsurg.2017.12.024. Epub 2018 Jan 5.

3.

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.

Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ.

Clin Cancer Res. 2017 Aug 1;23(15):4055-4065. doi: 10.1158/1078-0432.CCR-16-3206. Epub 2017 Mar 7.

4.

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.

Cyr AE, Tucker N, Ademuyiwa F, Margenthaler JA, Aft RL, Eberlein TJ, Appleton CM, Zoberi I, Thomas MA, Gao F, Gillanders WE.

J Am Coll Surg. 2016 Aug;223(2):399-407. doi: 10.1016/j.jamcollsurg.2016.04.048. Epub 2016 May 20.

5.

Key Tenets of Effective Surgery Leadership: Perspectives From the Society of Surgical Chairs Mentorship Sessions.

Rosengart TK, Kent KC, Bland KI, Britt LD, Eberlein TJ, Gewertz BL, Hunter JG, Lillemoe KD, Pellegrini CA, Schulick RD, Stain SC, Weigel RJ.

JAMA Surg. 2016 Aug 1;151(8):768-70. doi: 10.1001/jamasurg.2016.0405.

PMID:
27096328
6.

Surgical Training and the Early Specialization Program: Analysis of a National Program.

Klingensmith ME, Potts JR, Merrill WH, Eberlein TJ, Rhodes RS, Ashley SW, Valentine RJ, Hunter JG, Stain SC.

J Am Coll Surg. 2016 Apr;222(4):410-6. doi: 10.1016/j.jamcollsurg.2015.12.035. Epub 2016 Jan 14.

PMID:
27016968
7.

Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer.

Khwaja SS, Ivanovich J, DeWees TA, Ochoa L, Mullen DF, Thomas M, Margenthaler JA, Cyr A, Naughton M, Sanati S, Eberlein TJ, Gillanders WE, Aft RL, Zoberi JE, Zoberi I.

Cancer Med. 2016 Feb;5(2):230-8. doi: 10.1002/cam4.586. Epub 2015 Dec 21.

8.

Presidential Forum Discussion: Development of Surgical Scientists.

Weigel RJ, Upchurch GR Jr, Eberlein TJ, Lucas CE.

Ann Surg. 2015 Oct;262(4):555-62. doi: 10.1097/SLA.0000000000001400. No abstract available.

PMID:
26366534
9.

Delivering High-Quality Cancer Care: The Critical Role of Quality Measurement.

Spinks T, Ganz PA, Sledge GW Jr, Levit L, Hayman JA, Eberlein TJ, Feeley TW.

Healthc (Amst). 2014 Mar 1;2(1):53-62.

10.

A new paradigm in surgical training.

Eberlein TJ.

J Am Coll Surg. 2014 Apr;218(4):511-8. doi: 10.1016/j.jamcollsurg.2013.12.045. Epub 2014 Jan 24. No abstract available.

PMID:
24655837
11.

An institutional strategy to increase minority recruitment to therapeutic trials.

Anwuri VV, Hall LE, Mathews K, Springer BC, Tappenden JR, Farria DM, Jackson S, Goodman MS, Eberlein TJ, Colditz GA.

Cancer Causes Control. 2013 Oct;24(10):1797-809. doi: 10.1007/s10552-013-0258-1. Epub 2013 Jul 12.

12.

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.

Sanford DE, Belt BA, Panni RZ, Mayer A, Deshpande AD, Carpenter D, Mitchem JB, Plambeck-Suess SM, Worley LA, Goetz BD, Wang-Gillam A, Eberlein TJ, Denardo DG, Goedegebuure SP, Linehan DC.

Clin Cancer Res. 2013 Jul 1;19(13):3404-15. doi: 10.1158/1078-0432.CCR-13-0525. Epub 2013 May 7.

13.

Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.

Cyr A, Gao F, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

Ann Surg Oncol. 2012 Oct;19(10):3185-91. doi: 10.1245/s10434-012-2547-4. Epub 2012 Aug 14.

14.

Shaping a modern academic department of surgery: honoring the past; focusing on the future.

Eberlein TJ.

Ann Surg. 2012 Sep;256(3):395-401. doi: 10.1097/SLA.0b013e3182641299. No abstract available.

PMID:
22868359
15.

Compromised margins following mastectomy for stage I-III invasive breast cancer.

Yu J, Al Mushawah F, Taylor ME, Cyr AE, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

J Surg Res. 2012 Sep;177(1):102-8. doi: 10.1016/j.jss.2012.03.046. Epub 2012 Apr 10.

16.

Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors.

Atkins J, Al Mushawah F, Appleton CM, Cyr AE, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

J Surg Res. 2012 Sep;177(1):109-15. doi: 10.1016/j.jss.2012.03.045. Epub 2012 Apr 10.

17.

Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response.

Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

Ann Surg Oncol. 2012 Jan;19(1):253-8. doi: 10.1245/s10434-011-1877-y. Epub 2011 Jul 2.

18.

Breast cancer in elderly women (≥ 80 years): variation in standard of care?

Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

J Surg Oncol. 2011 Mar 1;103(3):201-6. doi: 10.1002/jso.21799. Epub 2010 Nov 23.

19.

Are we overtreating papillomas diagnosed on core needle biopsy?

Cyr AE, Novack D, Trinkaus K, Margenthaler JA, Gillanders WE, Eberlein TJ, Ritter J, Aft RL.

Ann Surg Oncol. 2011 Apr;18(4):946-51. doi: 10.1245/s10434-010-1403-7. Epub 2010 Nov 3.

20.

Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden.

Cyr A, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:303-11. doi: 10.1245/s10434-010-1255-1. Epub 2010 Sep 19.

21.

Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer.

Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA, Porembka MR, Herndon JM, Eberlein TJ, Goedegebuure P, Linehan DC.

J Immunol. 2010 Oct 1;185(7):4063-71. doi: 10.4049/jimmunol.0902609. Epub 2010 Aug 30.

22.

Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.

Johnston FM, Tan MC, Tan BR Jr, Porembka MR, Brunt EM, Linehan DC, Simon PO Jr, Plambeck-Suess S, Eberlein TJ, Hellstrom KE, Hellstrom I, Hawkins WG, Goedegebuure P.

Clin Cancer Res. 2009 Nov 1;15(21):6511-8. doi: 10.1158/1078-0432.CCR-09-0565. Epub 2009 Oct 20.

23.

Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer.

Tan MC, Al Mushawah F, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA.

Am J Surg. 2009 Oct;198(4):520-5. doi: 10.1016/j.amjsurg.2009.06.004.

24.
25.

The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy?

Pettit K, Swatske ME, Gao F, Salavaggione L, Gillanders WE, Aft RL, Monsees BS, Eberlein TJ, Margenthaler JA.

J Surg Oncol. 2009 Dec 1;100(7):553-8. doi: 10.1002/jso.21406.

26.

Predictors of primary breast abscesses and recurrence.

Bharat A, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA.

World J Surg. 2009 Dec;33(12):2582-6. doi: 10.1007/s00268-009-0170-8.

27.

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer.

Moo-Young TA, Larson JW, Belt BA, Tan MC, Hawkins WG, Eberlein TJ, Goedegebuure PS, Linehan DC.

J Immunother. 2009 Jan;32(1):12-21. doi: 10.1097/CJI.0b013e318189f13c.

28.

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer.

Tan MC, Goedegebuure PS, Belt BA, Flaherty B, Sankpal N, Gillanders WE, Eberlein TJ, Hsieh CS, Linehan DC.

J Immunol. 2009 Feb 1;182(3):1746-55.

29.

Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence.

Holwitt DM, Gillanders WE, Aft RL, Eberlein TJ, Margenthaler JA.

Am J Surg. 2008 Oct;196(4):562-5. doi: 10.1016/j.amjsurg.2008.06.009. Epub 2008 Aug 29.

30.

Scientific Presentation Award: The combination of axillary ultrasound and ultrasound-guided biopsy is an accurate predictor of axillary stage in clinically node-negative breast cancer patients.

Holwitt DM, Swatske ME, Gillanders WE, Monsees BS, Gao F, Aft RL, Eberlein TJ, Margenthaler JA.

Am J Surg. 2008 Oct;196(4):477-82. doi: 10.1016/j.amjsurg.2008.06.006. Epub 2008 Aug 23.

31.

Treatment and outcomes of patients with primary breast sarcoma.

Fields RC, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA.

Am J Surg. 2008 Oct;196(4):559-61. doi: 10.1016/j.amjsurg.2008.06.010. Epub 2008 Aug 23.

PMID:
18723152
32.

"The little red book"--sayings of chairman Brennan.

Eberlein TJ.

J Am Coll Surg. 2007 Oct;205(4 Suppl):S99-100. No abstract available.

PMID:
17916529
33.

Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology.

Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, Michelassi F, Singletary SE, Novotny P, Sloan J, Shanafelt TD.

Ann Surg Oncol. 2007 Nov;14(11):3043-53. Epub 2007 Sep 9.

PMID:
17828575
34.

Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy.

Fayanju OM, Ritter J, Gillanders WE, Eberlein TJ, Dietz JR, Aft R, Margenthaler JA.

Am J Surg. 2007 Oct;194(4):497-500.

PMID:
17826064
35.

Scientific Presentation Award. Patterns of local breast cancer recurrence after skin-sparing mastectomy and immediate breast reconstruction.

Vaughan A, Dietz JR, Aft R, Gillanders WE, Eberlein TJ, Freer P, Margenthaler JA.

Am J Surg. 2007 Oct;194(4):438-43.

PMID:
17826052
36.

Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.

Fields RC, Jeffe DB, Trinkaus K, Zhang Q, Arthur C, Aft R, Dietz JR, Eberlein TJ, Gillanders WE, Margenthaler JA.

Ann Surg Oncol. 2007 Dec;14(12):3345-51. Epub 2007 Aug 9.

PMID:
17687611
37.

Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies.

Viehl CT, Frey DM, Phommaly C, Chen T, Fleming TP, Gillanders WE, Eberlein TJ, Goedegebuure PS.

Breast Cancer Res Treat. 2008 May;109(2):305-14. Epub 2007 Jul 26.

PMID:
17653857
38.

Metastatic disease to the breast: the Washington University experience.

Vaughan A, Dietz JR, Moley JF, Debenedetti MK, Aft RL, Gillanders WE, Eberlein TJ, Ritter J, Margenthaler JA.

World J Surg Oncol. 2007 Jul 5;5:74.

39.

Assessing the state of surgical oncology: the future is now.

Eberlein TJ.

Ann Surg Oncol. 2006 Nov;13(11):1345-53. Epub 2006 Oct 1. Review.

PMID:
17013689
40.

Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.

Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, Goedegebuure PS, Linehan DC.

Ann Surg Oncol. 2006 Sep;13(9):1252-8. Epub 2006 Sep 3.

PMID:
16952047
41.

Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.

Liyanage UK, Goedegebuure PS, Moore TT, Viehl CT, Moo-Young TA, Larson JW, Frey DM, Ehlers JP, Eberlein TJ, Linehan DC.

J Immunother. 2006 Jul-Aug;29(4):416-24.

PMID:
16799337
42.

Introduction of Dr. S. Eva Singletary.

Eberlein TJ.

Ann Surg Oncol. 2005 Nov;12(11):845-7. Epub 2005 Sep 23. No abstract available.

PMID:
16189642
43.

Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.

Viehl CT, Tanaka Y, Chen T, Frey DM, Tran A, Fleming TP, Eberlein TJ, Goedegebuure PS.

Breast Cancer Res Treat. 2005 Jun;91(3):271-8.

PMID:
15952060
44.

A tat fusion protein-based tumor vaccine for breast cancer.

Viehl CT, Becker-Hapak M, Lewis JS, Tanaka Y, Liyanage UK, Linehan DC, Eberlein TJ, Goedegebuure PS.

Ann Surg Oncol. 2005 Jul;12(7):517-25. Epub 2005 May 10.

PMID:
15889213
45.

[Significance if ICAM-1 on lysis of human pancreatic carcinoma cells by autologous, cytotoxic T-lymphocytes].

Peiper M, Goedegebuure PS, Eberlein TJ, Broelsch CE.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):59-62. German.

PMID:
14518213
46.

Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.

Tanaka Y, Amos KD, Fleming TP, Eberlein TJ, Goedegebuure PS.

Surgery. 2003 Jan;133(1):74-80.

PMID:
12563241
47.

Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells.

Tanaka Y, Dowdy SF, Linehan DC, Eberlein TJ, Goedegebuure PS.

J Immunol. 2003 Feb 1;170(3):1291-8.

48.

Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.

Peiper M, Goedegebuure PS, Alldinger I, Knoefel WT, Izbicki JR, Eberlein TJ.

Anticancer Res. 2002 Nov-Dec;22(6A):3357-63.

PMID:
12530087
49.

Human dendritic cells induce tumor-specific apoptosis by soluble factors.

Joo HG, Fleming TP, Tanaka Y, Dunn TJ, Linehan DC, Goedegebuure PS, Eberlein TJ.

Int J Cancer. 2002 Nov 1;102(1):20-8.

50.

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.

Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC.

J Immunol. 2002 Sep 1;169(5):2756-61.

Supplemental Content

Loading ...
Support Center